C terminus

(redirected from Carboxyl terminal)
Also found in: Encyclopedia.

C ter·mi·nus

the end of a peptide or protein having a free carboxyl (-COOH) group.

C terminus

The end of a polypeptide chain, which has a free (unattached) carboxyl (COOH) group.

C ter·mi·nus

(tĕr'mi-nŭs)
The end of a peptide or protein having a free carboxyl (-COOH) group.
References in periodicals archive ?
PROLOR's CTP technology is based on the naturally occurring human Carboxyl Terminal Peptide (CTP).
NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH.
Louis, is based on a short amino acid sequence that occurs naturally in humans, the carboxyl terminal peptide (CTP).
Louis and is based on a short amino acid sequence that occurs naturally in humans, the carboxyl terminal peptide (CTP).
Louis and is based on a short amino acid sequence, the Carboxyl Terminal Peptide (CTP).
Modigene's technology is based on a short amino acid sequence, the carboxyl terminal peptide (CTP).
BULLETIN BOARD: MODG) today reported that researchers will publish a study in the October edition of the journal Endocrinology showing that erythropoietin (EPO) linked to Modigene's carboxyl terminal peptide (CTP) technology significantly increased the half-life of standard EPO in animal models.
Louis, Missouri and is based on a short amino acid sequence, the Carboxyl Terminal Peptide (CTP).